O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+7.57%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$4.43B
AUM Growth
–
Cap. Flow
+$4.4B
Cap. Flow
% of AUM
99.27%
Top 10 Holdings %
Top 10 Hldgs %
40.13%
Holding
117
New
107
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Amgen
AMGN
|
$258M |
| 2 |
Gilead Sciences
GILD
|
$247M |
| 3 |
Biogen
BIIB
|
$221M |
| 4 |
Merck
MRK
|
$192M |
| 5 |
Viatris
VTRS
|
$155M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 85.21% |
| 2 | Financials | 2.18% |
| 3 | Technology | 0.15% |
| 4 | Utilities | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QLTI
101
DELISTED
QLT Inc
QLTI
| $2.47M | 0.05% |
+563,000
| New | +$2.47M |
|
|
ITMN
102
DELISTED
INTERMUNE INC
ITMN
| $2.27M | 0.05% |
+236,000
| New | +$2.27M |
|
|
GIVN
103
DELISTED
GIVEN IMAGING LTD
GIVN
| $1.68M | 0.04% |
+120,000
| New | +$1.68M |
|
|
AUXL
104
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $998K | 0.02% |
+60,000
| New | +$998K |
|
105
Xtant Medical Holdings
XTNT
$82.4M
| $789K | 0.02% |
+14,620
| New | +$789K |
|
|
CHDX
106
DELISTED
CHINDEX INTL INC
CHDX
| $519K | 0.01% |
+32,000
| New | +$519K |
|
|
MR
107
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
| $449K | 0.01% |
+12,000
| New | +$449K |
|
108
Eli Lilly
LLY
$661B
| – | – |
0
| – | – |
|
109
SPDR S&P 500 ETF Trust
SPY
$656B
| – | – |
0
| – | – |
|
110
SPDR S&P Biotech ETF
XBI
$5.29B
| – | – |
0
| – | – |
|
|
ONCT
111
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| – | – |
0
| – | – |
|
|
SGEN
112
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – |
0
| – | – |
|
|
ELN
113
DELISTED
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
| – | – |
0
| – | – |
|